Skip to main content
Equibles
EMED logo

EMED · Electromedical Technologies, Inc

Track EMED — free

Use EMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 +0.00 (+0.00%) At close · Oct 23
Rebalance outlook locked
Going-concern doubt — flagged Nov 19, 2024

Substantial doubt about the company's ability to continue as a going concern.

“These factors, among others, raise substantial doubt regarding the Company’s ability to continue as a going concern.”
View the 10-Q filed Nov 19, 2024
Market Cap
$85,504
Shares
855.04M
Volume · Oct 23 2.03M Avg daily vol (3M) 6.78M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–0.00 Avg vol 30d8.5M Short int107K · 0.0% float · 1.0d Short vol2% DataJan 2020–Oct 2026 Filing10-Q · Nov 19

Up next

Latest filing: 10-Q
filed Nov 19, 2024

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$922,010
Trailing 12 months
Net income (TTM)
−$1.68M
Trailing 12 months
Revenue growth YoY
-86.9%
Year over year
Operating margin
-109.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$62,296
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+479.3%
Year over year · more shares
Price change (1Y)
+0.0%
Trailing year
Short interest
—
Latest settlement
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol High
Market backdrop VIX 19.5 · elevated Equity put/call 0.67
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −50%
below
Price vs 50-day avg 0%
above
RSI (14) 48
neutral
MACD trend Negative
52-week position 0%
near low
Momentum
relative strength
Very Weak
1-month return 0%
trailing
6-month return −50%
trailing
YTD return −50%
this year
Relative strength −56%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Strong
Revenue growth +17%
Y/Y
Gross margin 78%
expanding
EPS growth +100%
Y/Y
Free cash flow $-1.6M
Balance sheet $62.3K
net debt
Quant / Vol
risk profile
High
Volatility 547%
annualized · 1-yr
Max drawdown −50%
past year
ATR 0.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−50% Bearish
Price vs 50-day avg
0% Neutral
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $0
vs 200-day avg -50% vs 50-day avg +0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
EMED
Electromedical Technologies, Inc
this stock
$85,504 -50.0% +17.3% — 0.0%
ABT
Abbott Laboratories
 $181.86B -17.2% +5.7% 33.6 0.8%
MDT
Medtronic plc
 $122.04B -0.7% +8.4% 23.5 3.1%
SYK
Stryker Corp
 $116.86B -12.6% +11.2% 31.6 1.5%
BSX
Boston Scientific Corp
 $66.22B -52.1% +12.5% 18.5 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
107.2K
Days to cover
1.0d
Change
+107.2K sh
View
Short Volume
Short vol %
2%
As of
Oct 23, 2026
Short Total
View
Fails to Deliver
FTD shares
403
Value
$4
As of
Jan 23, 2023
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 21, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.3M
Net income (FY)
$-2.6M
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
NT 10-K
Filed
Mar 31, 2025
This year
0
View

Performance

5D 20D 120D MTD YTD
EMED +0.0% +0.0% -50.0% +0.0% -50.0%
SPY -0.4% -1.5% +5.8% -0.4% +11.5%
vs SPY +0.4% +1.5% -55.8% +0.4% -61.5%
Key facts CIK 1715819 Visit website Investor relations